{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:08:55Z","timestamp":1762459735741,"version":"3.37.3"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T00:00:00Z","timestamp":1556236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Trauma Emerg Surg"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00068-019-01144-y","type":"journal-article","created":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T04:09:13Z","timestamp":1556338153000},"page":"287-299","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Do antiosteoporotic drugs improve bone regeneration in vivo?"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8265-1840","authenticated-orcid":false,"given":"Maximilian","family":"Leiblein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Henrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Fervers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Kontradowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingo","family":"Marzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Seebach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,26]]},"reference":[{"key":"1144_CR1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s001980050076","volume":"8","author":"C Matthis","year":"1998","unstructured":"Matthis C, Weber U, O\u2019Neill TW, Raspe H. Health impact associated with vertebral deformities: results from the European Vertebral Osteoporosis Study (EVOS). Osteoporos Int. 1998;8:364\u201372.","journal-title":"Osteoporos Int"},{"key":"1144_CR2","first-page":"63","volume":"104","author":"JE Morley","year":"2007","unstructured":"Morley JE. Falls\u2014where do we stand? Mo Med. 2007;104:63\u20137.","journal-title":"Mo Med"},{"key":"1144_CR3","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","volume":"17","author":"O Johnell","year":"2006","unstructured":"Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17:1726\u201333.","journal-title":"Osteoporos Int"},{"key":"1144_CR4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/1520-6300(200102\/03)13:2<235::AID-AJHB1034>3.0.CO;2-M","volume":"13","author":"HM Frost","year":"2001","unstructured":"Frost HM. Cybernetic aspects of bone modeling and remodeling, with special reference to osteoporosis and whole-bone strength. Am J Hum Biol. 2001;13:235\u201348 (John Wiley & Sons, Inc).","journal-title":"Am J Hum Biol"},{"key":"1144_CR5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s001980200047","volume":"13","author":"CA Lill","year":"2002","unstructured":"Lill CA, Gerlach UV, Eckhardt C, Goldhahn J, Schneider E. Bone changes due to glucocorticoid application in an ovariectomized animal model for fracture treatment in osteoporosis. Osteoporos Int. 2002;13:407\u201314.","journal-title":"Osteoporos Int"},{"key":"1144_CR6","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/17453670510045318","volume":"76","author":"P Aspenberg","year":"2009","unstructured":"Aspenberg P. Drugs and fracture repair. Acta Orthopaedica. Taylor & Francis. 2009;76:741\u20138.","journal-title":"Acta Orthopaedica. Taylor & Francis"},{"key":"1144_CR7","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00198-015-3331-7","volume":"27","author":"V Hegde","year":"2016","unstructured":"Hegde V, Jo JE, Andreopoulou P, Lane JM. Effect of osteoporosis medications on fracture healing. Osteoporos Int Springer Lond. 2016;27:861\u201371.","journal-title":"Osteoporos Int Springer Lond"},{"key":"1144_CR8","first-page":"11","volume":"56","author":"VI Shevtsov","year":"1997","unstructured":"Shevtsov VI. Professor G. A. Ilizarov\u2019s contribution to the method of transosseous osteosynthesis. Bull Hosp Jt Dis. 1997;56:11\u20135.","journal-title":"Bull Hosp Jt Dis"},{"key":"1144_CR9","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.orthres.2003.08.018","volume":"22","author":"C Seebach","year":"2004","unstructured":"Seebach C, Skripitz R, Andreassen TT, Aspenberg P. Intermittent parathyroid hormone (1-34) enhances mechanical strength and density of new bone after distraction osteogenesis in rats. J. Orthop. Res. 2004;22:472\u20138 (Wiley Subscription Services, Inc., A Wiley Company).","journal-title":"J. Orthop. Res"},{"issue":"549785","key":"1144_CR10","first-page":"10","volume":"2014","author":"G Zacchetti","year":"2014","unstructured":"Zacchetti G, Dayer R, Rizzoli R, Ammann P. Systemic treatment with strontium ranelate accelerates the filling of a bone defect and improves the material level properties of the healing bone. Biomed Res Int. Hindawi. 2014;2014(549785):10.","journal-title":"Biomed Res Int. Hindawi"},{"issue":"Suppl 1","key":"1144_CR11","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1007\/s40520-013-0096-8","volume":"25","author":"U Tarantino","year":"2013","unstructured":"Tarantino U, Saturnino L, Scialdoni A, Feola M, Liuni FM, Tempesta V, et al. Fracture healing in elderly patients: new challenges for antiosteoporotic drugs. Aging Clin Exp Res. 2013;25(Suppl 1):S105\u20138.","journal-title":"Aging Clin Exp Res"},{"key":"1144_CR12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.injury.2011.03.061","volume":"42","author":"SV Bukata","year":"2011","unstructured":"Bukata SV. Systemic administration of pharmacological agents and bone repair: what can we expect. Injury. 2011;42:605\u20138.","journal-title":"Injury"},{"key":"1144_CR13","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.bone.2009.12.008","volume":"46","author":"M Saito","year":"2010","unstructured":"Saito M, Shiraishi A, Ito M, Sakai S, Hayakawa N, Mihara M, et al. Comparison of effects of alfacalcidol and alendronate on mechanical properties and bone collagen cross-links of callus in the fracture repair rat model. Bone. 2010;46:1170\u20139.","journal-title":"Bone"},{"key":"1144_CR14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.regpep.2010.03.003","volume":"162","author":"M Yamashita","year":"2010","unstructured":"Yamashita M, Otsuka F, Mukai T, Yamanaka R, Otani H, Matsumoto Y, et al. Simvastatin inhibits osteoclast differentiation induced by bone morphogenetic protein-2 and RANKL through regulating MAPK, AKT and Src signaling. Regul Pept. 2010;162:99\u2013108.","journal-title":"Regul Pept"},{"issue":"Suppl 1","key":"1144_CR15","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/S0020-1383(16)30003-1","volume":"47","author":"J-M F\u00e9ron","year":"2016","unstructured":"F\u00e9ron J-M, Mauprivez R. Fracture repair: general aspects and influence of osteoporosis and anti-osteoporosis treatment. Injury. 2016;47(Suppl 1):S10\u20134.","journal-title":"Injury"},{"key":"1144_CR16","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1302\/0301-620X.82B1.0820138","volume":"82","author":"R Skripitz","year":"2000","unstructured":"Skripitz R, Andreassen TT, Aspenberg P. Parathyroid hormone (1-34) increases the density of rat cancellous bone in a bone chamber. A dose-response study. J Bone Joint Surg Br. 2000;82:138\u201341.","journal-title":"J Bone Joint Surg Br."},{"key":"1144_CR17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrrheum.2014.164","volume":"11","author":"TA Einhorn","year":"2015","unstructured":"Einhorn TA, Gerstenfeld LC. Fracture healing: mechanisms and interventions. Nat Rev Rheumatol Nat Publish Group. 2015;11:45\u201354.","journal-title":"Nat Rev Rheumatol Nat Publish Group"},{"key":"1144_CR18","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1210\/jc.2004-1774","volume":"90","author":"JY Reginster","year":"2005","unstructured":"Reginster JY, Seeman E, De Vernejoul MC, Adami S, Compston J, Phenekos C, et al. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: treatment of peripheral osteoporosis (TROPOS) study. J Clin Endocrinol Metab. 2005;90:2816\u201322.","journal-title":"J Clin Endocrinol Metab"},{"key":"1144_CR19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/8756-3282(96)00080-4","volume":"18","author":"E Canalis","year":"1996","unstructured":"Canalis E, Hott M, Deloffre P, Tsouderos Y, Marie PJ. The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro. Bone. 1996;18:517\u201323.","journal-title":"Bone"},{"key":"1144_CR20","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1359\/jbmr.2003.18.6.1082","volume":"18","author":"N Takahashi","year":"2003","unstructured":"Takahashi N, Sasaki T, Tsouderos Y. Suda T (2003) S 12911-2 inhibits osteoclastic bone resorption in vitro. J. Bone Miner. Res. 2003;18:1082\u20137 (John Wiley and Sons and The American Society for Bone and Mineral Research (ASBMR)).","journal-title":"J. Bone Miner. Res."},{"key":"1144_CR21","first-page":"253","volume":"8","author":"L Cavalli","year":"2012","unstructured":"Cavalli L, Brandi ML. Targeted approaches in the treatment of osteoporosis: differential mechanism of action of denosumab and clinical utility. Ther Clin Risk Manag. Dove Press. 2012;8:253\u201366.","journal-title":"Ther Clin Risk Manag. Dove Press"},{"key":"1144_CR22","doi-asserted-by":"crossref","first-page":"35S","DOI":"10.1016\/S8756-3282(99)00044-7","volume":"24","author":"GR Mundy","year":"1999","unstructured":"Mundy GR. Cellular and molecular regulation of bone turnover. Bone. 1999;24:35S\u20138S.","journal-title":"Bone"},{"key":"1144_CR23","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1359\/jbmr.2002.17.11.2004","volume":"17","author":"B Skoglund","year":"2002","unstructured":"Skoglund B, Forslund C, Aspenberg P. Simvastatin improves fracture healing in mice. J. Bone Miner. Res. 2002;17:2004\u20138 (John Wiley and Sons and The American Society for Bone and Mineral Research (ASBMR)).","journal-title":"J. Bone Miner. Res."},{"key":"1144_CR24","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/1440-1681.12577","volume":"43","author":"A Moshiri","year":"2016","unstructured":"Moshiri A, Sharifi AM, Oryan A. Role of Simvastatin on fracture healing and osteoporosis: a systematic review on in vivo investigations. Clin Exp Pharmacol Physiol. 2016;43:659\u201384.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1144_CR25","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s11596-009-0304-0","volume":"29","author":"X Li","year":"2009","unstructured":"Li X, Wang P, Xu X, Wang Y, Xia Y, Wang D. Simvastatin increases the activity of endothelial nitric oxide synthase via enhancing phosphorylation. J Huazhong Univ Sci Technol Med Sci. 2009;29:286\u201390.","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"key":"1144_CR26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10195-010-0083-1","volume":"11","author":"MA Matos","year":"2010","unstructured":"Matos MA, Tannuri U, Guarniero R. The effect of zoledronate during bone healing. J Orthop Traumatol Springer Int Publish. 2010;11:7\u201312.","journal-title":"J Orthop Traumatol Springer Int Publish"},{"key":"1144_CR27","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/j.joms.2017.03.050","volume":"75","author":"J Vieira de","year":"2017","unstructured":"de Vieira J. S, Giovanini A, G\u00f6rhinger I, Gonzaga CC, Costa-Casagrande TA, Deliberador TM (2017) Use of low-dose alendronate improves cranial bone repair and is associated with an increase of osteocalcin: an experimental study. J Oral Maxillofac Surg. 2017;75:1873\u201381.","journal-title":"J Oral Maxillofac Surg."},{"key":"1144_CR28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.17305\/bjbms.2011.2622","volume":"11","author":"E Ku\u010dukali\u0107-Selimovi\u0107","year":"2011","unstructured":"Ku\u010dukali\u0107-Selimovi\u0107 E, Valjevac A, Had\u017eovi\u0107-D\u017euvo A, Skopljak-Beganovi\u0107 A, Alimanovic-Alagi\u0107 R, Brkovi\u0107 A. Evaluation of bone remodelling parameters after 1\u00a0year treatment with alendronate in postmenopausal women with osteoporosis. Bosn J Basic Med Sci. 2011;11:41\u20135.","journal-title":"Bosn J Basic Med Sci"},{"key":"1144_CR29","first-page":"83","volume":"3","author":"M Soroush","year":"2018","unstructured":"Soroush M, Khabbazi A, Malek Mahdavi A. Serum osteocalcin levels in postmenopausal osteoporotic women receiving alendronate. Rheumatology Research. Iran Rheumatol Assoc. 2018;3:83\u20139.","journal-title":"Iran Rheumatol Assoc"},{"key":"1144_CR30","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1359\/jbmr.070318","volume":"22","author":"N Amanat","year":"2007","unstructured":"Amanat N, McDonald M, Godfrey C, Bilston L, Little D. Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair. J. Bone Miner. Res. 2007;22:867\u201376 (John Wiley and Sons and The American Society for Bone and Mineral Research (ASBMR)).","journal-title":"J. Bone Miner. Res."},{"issue":"Suppl 1","key":"1144_CR31","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/S0020-1383(16)30015-8","volume":"47","author":"SL Kates","year":"2016","unstructured":"Kates SL, Ackert-Bicknell CL. How do bisphosphonates affect fracture healing? Injury. 2016;47(Suppl 1):S65\u20138.","journal-title":"Injury"},{"key":"1144_CR32","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.bone.2008.05.019","volume":"43","author":"MM McDonald","year":"2008","unstructured":"McDonald MM, Dulai S, Godfrey C, Amanat N, Sztynda T, Little DG. Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling. Bone. 2008;43:653\u201362.","journal-title":"Bone"},{"key":"1144_CR33","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1359\/jbmr.2002.17.12.2237","volume":"17","author":"Y Cao","year":"2002","unstructured":"Cao Y, Mori S, Mashiba T, Westmore MS, Ma L, Sato M, et al. Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats. J. Bone Miner. Res. 2002;17:2237\u201346 (John Wiley and Sons and The American Society for Bone and Mineral Research (ASBMR)).","journal-title":"J. Bone Miner. Res."},{"key":"1144_CR34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00423-008-0436-x","volume":"395","author":"EK Stuermer","year":"2010","unstructured":"Stuermer EK, Sehmisch S, Rack T, Wenda E, Seidlova-Wuttke D, Tezval M, et al. Estrogen and raloxifene improve metaphyseal fracture healing in the early phase of osteoporosis: A new fracture-healing model at the tibia in rat. Langenbecks Arch Surg. Springer Verlag. 2010;395:163\u201372.","journal-title":"Langenbecks Arch Surg. Springer Verlag"},{"key":"1144_CR35","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00774-013-0461-x","volume":"31","author":"AS Spiro","year":"2013","unstructured":"Spiro AS, Khadem S, Jeschke A, Marshall RP, Pogoda P, Ignatius A, et al. The SERM raloxifene improves diaphyseal fracture healing in mice. J Bone Miner Metab. 2013;31:629\u201336.","journal-title":"J Bone Miner Metab"},{"key":"1144_CR36","first-page":"349","volume":"29","author":"MJ Lobo","year":"1993","unstructured":"Lobo MJ, Remesar X, Alemany M. Effect of chronic intravenous injection of steroid hormones on body weight and composition of female rats. Biochem Mol Biol Int. 1993;29:349\u201358.","journal-title":"Biochem Mol Biol Int"},{"key":"1144_CR37","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1517\/14656560903127241","volume":"10","author":"L Gennari","year":"2009","unstructured":"Gennari L. Lasofoxifene, a new selective estrogen receptor modulator for the treatment of osteoporosis and vaginal atrophy. Expert Opin Pharmacother. 2009;10:2209\u201320.","journal-title":"Expert Opin Pharmacother"},{"key":"1144_CR38","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/jama.287.7.847","volume":"287","author":"E Barrett-Connor","year":"2002","unstructured":"Barrett-Connor E, Grady D, Sashegyi A, Anderson PW, Cox DA, Hoszowski K, et al. Raloxifene and cardiovascular events in osteoporotic postmenopausal women: 4-year results from the MORE (multiple outcomes of raloxifene evaluation) randomized trial. JAMA. 2002;287:847\u201357.","journal-title":"JAMA"},{"key":"1144_CR39","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s00198-008-0602-6","volume":"19","author":"RK Fuchs","year":"2008","unstructured":"Fuchs RK, Allen MR, Condon KW, Reinwald S, Miller LM, McClenathan D, et al. Strontium ranelate does not stimulate bone formation in ovariectomized rats. Osteoporos Int. Springer Verlag. 2008;19:1331\u201341.","journal-title":"Osteoporos Int. Springer Verlag"},{"key":"1144_CR40","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00198-015-3266-z","volume":"27","author":"M Scaglione","year":"2016","unstructured":"Scaglione M, Fabbri L, Casella F, Guido G. Strontium ranelate as an adjuvant for fracture healing: clinical, radiological, and ultrasound findings in a randomized controlled study on wrist fractures. Osteoporos Int. 2016;27:211\u20138.","journal-title":"Osteoporos Int"},{"key":"1144_CR41","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jbspin.2007.01.034","volume":"74","author":"O Cebesoy","year":"2007","unstructured":"Cebesoy O, Tutar E, Kose KC, Baltaci Y, Bagci C. Effect of strontium ranelate on fracture healing in rat tibia. Jt Bone Spine. 2007;74:590\u20133.","journal-title":"Jt Bone Spine"},{"key":"1144_CR42","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1016\/j.lpm.2011.07.010","volume":"40","author":"A-P Jonville-Bera","year":"2011","unstructured":"Jonville-Bera A-P. Autret-Leca E [adverse drug reactions of strontium ranelate (Protelos(\u00ae) in France]. Presse Med. 2011;40:e453\u201362.","journal-title":"Presse Med"},{"key":"1144_CR43","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1016\/j.injury.2015.08.034","volume":"46","author":"Z-S Tao","year":"2015","unstructured":"Tao Z-S, Zhou W-S, Tu K-K, Huang Z-L, Zhou Q, Sun T, et al. The effects of combined human parathyroid hormone (1-34) and simvastatin treatment on osseous integration of hydroxyapatite-coated titanium implants in the femur of ovariectomized rats. Injury. 2015;46:2164\u20139.","journal-title":"Injury"},{"key":"1144_CR44","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1471-2474-8-98","volume":"8","author":"B Skoglund","year":"2007","unstructured":"Skoglund B, Aspenberg P. Locally applied Simvastatin improves fracture healing in mice. BMC Musculoskelet Disord BioMed Cent. 2007;8:98.","journal-title":"BMC Musculoskelet Disord BioMed Cent"},{"key":"1144_CR45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00580-011-1372-7","volume":"22","author":"JI Ihedioha","year":"2011","unstructured":"Ihedioha JI, Noel-Uneke OA, Ihedioha TE. Reference values for the serum lipid profile of albino rats (Rattus norvegicus) of varied ages and sexes. Comp Clin Pathol. 2011;22:93\u20139.","journal-title":"Comp Clin Pathol."},{"key":"1144_CR46","first-page":"131","volume":"57","author":"K Tsunori","year":"2015","unstructured":"Tsunori K. Effects of parathyroid hormone dosage and schedule on bone regeneration. J Oral Sci Nihon Univ Sch Dent. 2015;57:131\u20136.","journal-title":"J Oral Sci Nihon Univ Sch Dent"},{"key":"1144_CR47","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1359\/jbmr.1999.14.6.960","volume":"14","author":"TT Andreassen","year":"1999","unstructured":"Andreassen TT, Ejersted C, Oxlund H. Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures. J. Bone Miner. Res. 1999;14:960\u20138 (John Wiley and Sons and The American Society for Bone and Mineral Research (ASBMR)).","journal-title":"J. Bone Miner. Res."},{"key":"1144_CR48","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00003086-199909000-00033","volume":"366","author":"G Holzer","year":"1999","unstructured":"Holzer G, Majeska RJ, Lundy MW, Hartke JR, Einhorn TA. Parathyroid hormone enhances fracture healing: A preliminary report. Clin Orthop Relat Res. 1999;366:258\u201363.","journal-title":"Clin Orthop Relat Res"},{"issue":"Suppl 1","key":"1144_CR49","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2106\/JBJS.G.01443","volume":"90","author":"GL Barnes","year":"2008","unstructured":"Barnes GL, Kakar S, Vora S, Morgan EF, Gerstenfeld LC, Einhorn TA. Stimulation of fracture-healing with systemic intermittent parathyroid hormone treatment. J Bone Joint Surg Am. 2008;90(Suppl 1):120\u20137.","journal-title":"J Bone Joint Surg Am"},{"key":"1144_CR50","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1359\/jbmr.1999.14.3.439","volume":"14","author":"Y Ma","year":"1999","unstructured":"Ma Y, Jee WS, Yuan Z, Wei W, Chen H, Pun S, et al. Parathyroid hormone and mechanical usage have a synergistic effect in rat tibial diaphyseal cortical bone. J. Bone Miner. Res. 1999;14:439\u201348 (John Wiley and Sons and The American Society for Bone and Mineral Research (ASBMR)).","journal-title":"J. Bone Miner. Res."},{"key":"1144_CR51","first-page":"1266","volume":"23","author":"R Skripitz","year":"2005","unstructured":"Skripitz R, B\u00f6hling S, R\u00fcther W, Aspenberg P. Stimulation of implant fixation by parathyroid hormone (1-34)-A histomorphometric comparison of PMMA cement and stainless steel. J. Orthop. Res. 2005;23:1266\u201370 (Wiley Subscription Services, Inc., A Wiley Company).","journal-title":"J. Orthop. Res."},{"key":"1144_CR52","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bone.2016.08.012","volume":"92","author":"M Casanova","year":"2016","unstructured":"Casanova M, Herelle J, Thomas M, Softley R, Schindeler A, Little D, et al. Effect of combined treatment with zoledronic acid and parathyroid hormone on mouse bone callus structure and composition. Bone. 2016;92:70\u20138.","journal-title":"Bone"},{"key":"1144_CR53","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ejphar.2010.10.058","volume":"650","author":"M Giner","year":"2011","unstructured":"Giner M, Rios MJ, Montoya MJ, V\u00e1zquez MA, Miranda C, P\u00e9rez-Cano R. Alendronate and raloxifene affect the osteoprotegerin\/RANKL system in human osteoblast primary cultures from patients with osteoporosis and osteoarthritis. Eur J Pharmacol. 2011;650:682\u20137.","journal-title":"Eur J Pharmacol"},{"key":"1144_CR54","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/emm.2002.21","volume":"34","author":"YH Kim","year":"2002","unstructured":"Kim YH, Kim G-S, Jeong-Hwa B. Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression. Exp Mol Med. 2002;34:145\u201351.","journal-title":"Exp Mol Med"},{"key":"1144_CR55","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1210\/en.2014-1046","volume":"155","author":"AN Ben-awadh","year":"2014","unstructured":"Ben-awadh AN, Delgado-Calle J, Tu X, Kuhlenschmidt K, Allen MR, Plotkin LI, et al. Parathyroid hormone receptor signaling induces bone resorption in the adult skeleton by directly regulating the RANKL gene in osteocytes. Endocrinology. 2014;155:2797\u2013809.","journal-title":"Endocrinology"},{"key":"1144_CR56","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1055\/s-2005-870538","volume":"37","author":"H Kaji","year":"2005","unstructured":"Kaji H, Kanatani M, Sugimoto T, Chihara K. Statins modulate the levels of osteoprotegerin\/receptor activator of NF\u03baB Ligand mRNA in mouse bone-cell cultures. Horm Metab Res. 2005;37:589\u201392 (Georg Thieme Verlag KG Stuttgart, New York).","journal-title":"Horm Metab Res"},{"key":"1144_CR57","doi-asserted-by":"crossref","first-page":"R2","DOI":"10.1186\/ar2348","volume":"10","author":"D Findlay","year":"2008","unstructured":"Findlay D, Chehade M, Tsangari H, Neale S, Hay S, Hopwood B, et al. Circulating RANKL is inversely related to RANKL mRNA levels in bone in osteoarthritic males. Arthritis Res Ther BioMed Cent. 2008;10:R2.","journal-title":"Arthritis Res Ther BioMed Cent"},{"key":"1144_CR58","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrg3185","volume":"13","author":"C Vogel","year":"2012","unstructured":"Vogel C, Marcotte EM. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet Nat Publish Group. 2012;13:227\u201332.","journal-title":"Nat Rev Genet Nat Publish Group"},{"key":"1144_CR59","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1016\/j.febslet.2009.10.036","volume":"583","author":"T Maier","year":"2009","unstructured":"Maier T, G\u00fcell M, Serrano L. Correlation of mRNA and protein in complex biological samples. FEBS Lett. 2009;583:3966\u201373.","journal-title":"FEBS Lett"},{"key":"1144_CR60","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.injury.2010.02.017","volume":"41","author":"C Seebach","year":"2010","unstructured":"Seebach C, Schultheiss J, Wilhelm K, Frank J, Henrich D. Comparison of six bone-graft substitutes regarding to cell seeding efficiency, metabolism and growth behaviour of human mesenchymal stem cells (MSC) in vitro. Injury. 2010;41:731\u20138.","journal-title":"Injury"}],"container-title":["European Journal of Trauma and Emergency Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00068-019-01144-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00068-019-01144-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00068-019-01144-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T23:29:36Z","timestamp":1587770976000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00068-019-01144-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,26]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1144"],"URL":"https:\/\/doi.org\/10.1007\/s00068-019-01144-y","relation":{},"ISSN":["1863-9933","1863-9941"],"issn-type":[{"type":"print","value":"1863-9933"},{"type":"electronic","value":"1863-9941"}],"subject":[],"published":{"date-parts":[[2019,4,26]]},"assertion":[{"value":"26 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Maximilian Leiblein, Dirk Henrich, Florian Fervers, Kerstin Kontradowitz, Ingo Marzi and Caroline Seebach declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}